RecallDepth
Class III Terminated

Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 51079-947-08.

Company
Mylan Institutional, Inc. (D.B.A. Udl Laboratories)
Recall Initiated
July 3, 2014
Posted
July 23, 2014
Recall Number
D-1435-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,184 cartons
Firm Location
Rockford, IL, United States

Reason for Recall

Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.

Distribution

Nationwide, Puerto Rico, and Guam.

Lot / Code Info

Lot #: 3045659, 3048256, Exp 07/14

More recalls by Mylan Institutional, Inc. (D.B.A. Udl Laboratories)

View all recalls by this company →

Other recent Class III Drug recalls